🔎 Trials Near Me

Home › Astrocytoma › Massachusetts

Pag-aaral pangklinika para sa Astrocytoma sa Massachusetts

13 pag-aaral para sa Astrocytoma ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07215910

Implantable Microdevice In Primary Brain Tumors

  • Brigham and Women's Hospital, Boston
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT04135807

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05303519

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Boston
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Tufts Medical Center, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

Targeted Pediatric High-Grade Glioma Therapy

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Serial MRI Scans During Radiation Therapy

  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535

Study of Olutasidenib and Temozolomide in HGG

  • Susan Chi, Boston
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

  • Massachusetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Peb 28, 2024 · NCT06283927

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

  • Massachusetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Peb 22, 2024 · NCT06118723

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

  • Massachusetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 90 · Lahat ng kasarian · Na-update Peb 22, 2024 · NCT06273176

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.